UK Immunotherapy Study: Reanalysis by a combined symptom and medication score

J Allergy Clin Immunol. 2018 Dec;142(6):1998-1999.e3. doi: 10.1016/j.jaci.2018.07.034. Epub 2018 Aug 24.

¹ Department of Respiratory Medicine, Royal Sussex County Hospital, Brighton, United Kingdom.
² Global Clinical Development, ALK-Abelló, Hørsholm, Denmark.
³ ALK-Abelló Arzneimittel GmbH Clinical Development/Medical Department, Hamburg, Germany.
⁴ ALK-Abelló Arzneimittel GmbH Clinical Development/Medical Department, Hamburg, Germany; Universitätsklinikum Carl Gustav Carus, Clinic for Otolaryngology, Dresden, Germany.
⁵ Allergy and Clinical Immunology, Section Inflammation, Repair and Development, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom.
⁶ Department of Allergy, Guys Hospital, London and Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
⁷ School of Molecular Medical Sciences, Faculty of Medicine and Health Science, University of Nottingham, Nottingham, United Kingdom.
⁸ Department of Otorhinolaryngology, Head and Neck Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Center for Rhinology and Allergology, Wiesbaden, Germany. Electronic address: [email protected].

No abstract available

Publication types